Cargando…
Vaccine Breakthrough Severe COVID-19 in a Lung Recipient
The vaccines developed against severe acute respiratory syndrome coronavirus 2 are seen as the most crucial weapon in controlling the epidemic. It has been reported in early-stage vaccine studies that vaccines provide up to 95% protection against severe disease and mortality, even in the absence of...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585586/ https://www.ncbi.nlm.nih.gov/pubmed/34887098 http://dx.doi.org/10.1016/j.transproceed.2021.11.003 |